University of Maryland
College Park
Maryland
20742
United States
176 articles about University of Maryland
-
NIH Awards $14.4 Million to NDRI to Collaborate on the Somatic Mosaicism across Human Tissues (SMaHT) Network
5/17/2023
The National Disease Research Interchange, in collaboration with the University of Maryland School of Medicine and Johns Hopkins All Children’s Hospital, has been awarded a research grant of $14.4M by the National Institutes of Health with a goal to transform our knowledge of how much genetic variation there is in cells and tissues throughout our bodies.
-
The Caris Precision Oncology Alliance Welcomes the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
5/3/2023
Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, announced that the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance™.
-
GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio, Broadens Pipeline
7/26/2022
GEn1E plans to use the novel discovery, which is licensed from University of Maryland, Baltimore to develop therapies for pulmonary, oncology and muscle degenerative diseases.
-
The same advantage against HIV-1 possessed by a person with the inactive CCR5 variant potentially doubles as resistance to any virus that capitalizes on or manipulates that receptor.
-
The researchers believe Keytruda and possibly other anti-PD-1 checkpoint inhibitors might help the immune system track the last signs of HIV while also preventing HIV’s ability to hide.
-
$12 Million Developmental Genotype-Tissue Expression Project Award Announcement
9/30/2021
The National Disease Research Interchange, in collaboration with Children’s Hospital of Philadelphia, the University of Maryland’s Medicine Department of Pediatrics, and John Hopkins All Children’s Hospital have been awarded a research grant of $12.5M over five years to collaborate on the developmental Genotype-Tissue Expression project.
-
UM School of Medicine Helps Maryland Conduct State-Wide Sequencing Of COVID Variants
4/29/2021
UMSOM's Institute for Genome Sciences Working with State of Maryland to Sequence More Than 10 Percent of Positive COVID Tests
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
RNA Disease Diagnostics, Inc. Takes Exclusive License to Cutting-Edge Molecular RNA Diagnostic Platform Technology from UMB and UMBC
2/4/2021
RNA Disease Diagnostics, Inc. (RNADD) has secured an exclusive global license to a cutting-edge sensor technology jointly owned by University of Maryland, Baltimore (UMB) and the University of Maryland, Baltimore County (UMBC). RNADD's first product will be a rapid point-of-care (POC) COVID-19 test with accuracy, sensitivity, and sp
-
University of Maryland Study Finds Neuvana Technology Helps Language Learning in Adults
1/11/2021
Vagus Nerve Stimulation using Neuvana’s patented headphones showed improved speed and accuracy when learning Mandarin Chinese
-
A novel way to control biologic signaling allows cellular function to be modulated via cell phone, according to research presented at the American Chemical Society’s annual meeting Tuesday by researchers at the University of Maryland.
-
UM School of Medicine Researchers Receive Federal Funding to Rapidly Test New Treatments for COVID-19
6/16/2020
Long-time Coronavirus Researcher Joins Collaboration to Rapidly Repurpose FDA-approved Drugs for COVID-19
-
NYU Langone Among First Centers to Enroll Patients in US Clinical Trial for COVID-19 mRNA Vaccine
5/5/2020
The first U.S. patients have been dosed in a clinical trial testing whether four experimental mRNA vaccine candidates can prevent infection with the virus that causes COVID-19 disease..
-
Illumina Celebrates Grand Opening of Its Solutions Center in the University of Maryland BioPark
10/29/2019
13,000-square-foot training facility is the first East Coast location for Illumina, a California-based global leader in genomics
-
KaloCyte Relocates to Downtown Baltimore as Co-Founders Join University of Maryland Faculty
9/23/2019
Biotechnology Company Is Developing Synthetic Blood Product for Use in Trauma Settings
-
Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer Study
9/23/2019
Anixa Biosciences, Inc. announced that Mohummad Siddiqui, MD, Associate Professor of Surgery at the University of Maryland School of Medicine has joined its ongoing prostate cancer Cchek™ study.
-
Krishnan Suthanthiran, President & Founder of TeamBest Companies & Best Cure Foundation, Presents the AAPM Best Award to its 2019 Recipients in San Antonio, Texas, at the AAPM Annual Meeting
7/15/2019
On July 15th, Krishnan Suthanthiran, President & Founder of TeamBest Companies and Best Cure Foundation, presented the AAPM Best Award to the 2019 recipients at the Annual Meeting of the American Association of Physicists in Medicine taking place in San Antonio, Texas, USA July 14–17, 2019.
-
Laser Method Promising for Detecting Trace Chemicals in Air
6/20/2019
Approach offers highly sensitive way to scan large areas for radioactive material, chemicals, or pollution
-
ChoiceOne Urgent Care Partners with Coppermine Fieldhouse
4/11/2019
ChoiceOne Urgent Care in partnership with University of Maryland St. Joseph Medical Center is pleased to announce a new community sponsorship opportunity with Coppermine Fieldhouse, a provider of indoor and outdoor programs, camps, clinics, special events and clubs for children and adults throughout the state of Maryland.
-
University of Maryland School of Dentistry Researcher Leads Search for Vaccine Adjuvants
12/22/2018
Professor Robert K. Ernst, PhD, of the University of Maryland School of Dentistry (UMSOD) has been awarded a five-year, $6.4 million contract from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) to develop and test new adjuvants for use in future vaccines. An adjuvant is added to a vaccine to, as NIAID notes, "enhance its ability to induce protection against infection."